Recent advances in multiple antigen peptides.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  JIM - Journal of Immunological Methods

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0022-1759(96)00066-XPMID 8841440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity.

  2009cited by this paper
• Unprotected peptides as building blocks for branched peptides and peptide dendrimers.

  2009cited by this paper
• Cyclic V3-loop-related HIV-1 conjugate vaccines. Synthesis, conformation and immunological properties.

  2009cited by this paper
• A new synthetic functionalized antigen carrier.

  2009cited by this paper
• A novel strategy for the synthesis of the cysteine-rich protective antigen of the malaria merozoite surface protein (MSP-1). Knowledge-based strategy for disulfide formation.

  2009cited by this paper
• Affinity enhancement of complementary peptide recognition.

  2009cited by this paper
• Specificity and formation of unusual amino acids of an amide ligation strategy for unprotected peptides.

  2009cited by this paper
• Synthesis of a diepitope multiple antigen peptide containing sequences from two malaria antigens using Fmoc chemistry.

  1995cited by this paper
• Loligomers: design of de novo peptide-based intracellular vehicles.

  1995cited by this paper
• Unprotected Peptides as Building Blocks for the Synthesis of Peptide Dendrimers with Oxime, Hydrazone, and Thiazolidine Linkages

  1995cited by this paper
• Cyclisation of totally unprotected peptides in aqueous solution by oxime formation

  1995cited by this paper
• Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line

  1995cited by this paper
• Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA.

  1995cited by this paper
• Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages

  1994cited by this paper
• Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses.

  1994cited by this paper
• Immunization and affinity purification of antibodies using resin-immobilized lysine-branched synthetic peptides.

  1994cited by this paper
• Evaluation of the effect of Sm28GST-derived peptides in murine hepatosplenic schistosomiasis: interest of the lipopeptidic form of the C-terminal peptide.

  1994cited by this paper
• A Multimeric Synthetic Peptide Combinatorial Library.

  1994cited by this paper
• Structural and functional properties of region II-plus of the malaria circumsporozoite protein

  1994cited by this paper
• An unusual heparin-binding peptide from the carboxy-terminal hep-2 region of fibronectin.

  1994cited by this paper
• Synthesis of Peptide Dendrimer

  1994cited by this paper
• Peptide segment ligation strategy without use of protecting groups.

  1994cited by this paper
• Synthesis of proteins by native chemical ligation.

  1994cited by this paper
• Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine.

  1994cited by this paper
• Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells.

  1994cited by this paper
• Antibody against branched epitope as an affinity ligand to separate the parent protein.

  1994cited by this paper
• Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.

  1994cited by this paper
• Leucine-specific binding of photoreactive Leu7-MAP to a high molecular weight protein on the plasma membrane of the isolated rat hepatocyte.

  1994cited by this paper
• Inhibition of macroautophagy and proteolysis in the isolated rat hepatocyte by a nontransportable derivative of the multiple antigen peptide Leu8-Lys4-Lys2-Lys-beta Ala.

  1994cited by this paper
• Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic Tyr-Ile-Gly-Ser-Arg (YIGSR)-containing polypeptide from laminin.

  1994cited by this paper
• Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition.

  1994cited by this paper
• Facile synthesis of homogeneous artificial proteins

  1994cited by this paper
• Lymphocytes and promonocytes attach to the synthetic [Tyr5,12, Lys7]- polyphemusin II peptide.

  1994cited by this paper
• The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.

  1994cited by this paper
• Melanoma cell adhesion and spreading activities of a synthetic 124-residue triple-helical "mini-collagen".

  1993cited by this paper
• Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis.

  1993cited by this paper
• Template assembled synthetic proteins: Condensation of a multifunctional peptide to a topological template via chemoselective ligation

  1993cited by this paper
• Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes

  1993cited by this paper
• Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein‐Barr virus‐encoded nuclear antigen EBNA I

  1993cited by this paper
• Comprehensive delineation of antigenic and immunogenic properties of peptides derived from the nef HIV-1 regulatory protein.

  1993cited by this paper
• Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum.

  1993cited by this paper
• Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide.

  1993cited by this paper
• Peptide-based assay for the identification of endothelin-converting enzyme inhibitors.

  1993cited by this paper
• Effects of adjuvants and multiple antigen peptides on humoral and cellular immune responses to gp160 of HIV-1.

  1993cited by this paper
• Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3

  1993cited by this paper
• A novel lysine-protecting procedure for continuous flow solid phase synthesis of branched peptides

  1993cited by this paper
• Mapping of epitopes on the SmD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus.

  1993cited by this paper
• Biochemical and immunocytochemical characterization of antipeptide antibodies to a cloned GluR1 glutamate receptor subunit: cellular and subcellular distribution in the rat forebrain.

  1993cited by this paper
• T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages.

  1993cited by this paper
• Multimeric forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide enhance the inhibition of tumor growth and metastasis.

  1993cited by this paper
• Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes.

  1992cited by this paper
• Advantages of branched peptides in serodiagnosis. Detection of HIV-specific antibodies and the use of glycine spacers to increase sensitivity.

  1992cited by this paper
• Site-specific modification of a fragment of a chimeric monoclonal antibody using reverse proteolysis.

  1992cited by this paper
• Binding of human tumor necrosis factor alpha to multimeric complementary peptides.

  1992cited by this paper
• Macromolecular assemblage in the design of a synthetic AIDS vaccine.

  1992cited by this paper
• Analysis of antigenicity and immunogenicity of five different chemically defined constructs of a peptide.

  1992cited by this paper
• Oriented immobilization of peptide ligands on solid supports.

  1992cited by this paper
• Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes.

  1992cited by this paper
• Multiple autoepitope presentation for specific detection of antibodies in primary biliary cirrhosis

  1992cited by this paper
• Determination of B-cell epitopes of nef HIV-I protein: immunogenicity related to their structure.

  1992cited by this paper
• A chemically defined synthetic vaccine model for HIV-1.

  1992cited by this paper
• Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus.

  1992cited by this paper
• Development of a monoclonal antibody to the conserved region of p34cdc2 protein kinase.

  1992cited by this paper
• Construction of protein analogues by site-specific condensation of unprotected fragments.

  1992cited by this paper
• Design of a Complete Synthetic Peptide-Based AIDS Vaccine with a Built-in Adjuvant

  1992cited by this paper
• Rapid attachment of a helper T cell epitope to branched peptides by fragment condensation to give enhanced immunogenicity.

  1992cited by this paper
• Epitopic mapping of linear and conformation-dependent antigenic determinants on GP5 of five U.S. bluetongue viruses.

  1992cited by this paper
• Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes.

  1992cited by this paper
• Binding of human tumor necrosis factor α to multimeric complementary peptides

  1992cited by this paper
• Resolution of the histidine problem for thiol capture--synthesis of a 39-peptide

  1991cited by this paper
• Chemically unambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system.

  1991cited by this paper
• Multiple antigen peptides for specific detection of antibodies to a malaria antigen in human sera.

  1991cited by this paper
• Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein

  1991cited by this paper
• Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus.

  1991cited by this paper
• Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen.

  1991cited by this paper
• Generation of anti-peptide and anti-protein sera. Effect of peptide presentation on immunogenicity.

  1991cited by this paper
• Lack of H‐2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide

  1991cited by this paper
• Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications

  1991cited by this paper
• Design and synthesis of a peptide having chymotrypsin-like esterase activity.

  1990cited by this paper
• Structural probing of human lutropin using antibodies raised against synthetic peptides constructed by classical and multiple antigen peptide system approaches.

  1990cited by this paper
• A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H‐2 haplotypes

  1990cited by this paper
• Lipidic peptides, I. Synthesis, resolution and structural elucidation of lipidic amino acids and their homo- and hetero-oligomers

  1990cited by this paper
• Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

  1990cited by this paper
• Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes.

  1989cited by this paper
• Hepatitis B virus surface antigen (HBsAg) as carrier for synthetic peptides having an attached hydrophobic tail.

  1989cited by this paper
• A Chemical Approach to Protein Design—Template‐Assembled Synthetic Proteins (TASP)

  1989cited by this paper
• Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten.

  1989cited by this paper
• Peptide synthesis by prior thiol capture. 6. Rates of the disulfide-bond-forming capture reaction and demonstration of the overall strategy by synthesis of the C-terminal 29-peptide sequence of BPTI

  1989cited by this paper
• Multiple antigen peptide. A novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays.

  1989cited by this paper
• In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

  1989cited by this paper
• Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants

  1988cited by this paper
• Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

  1988cited by this paper
• A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain.

  1988cited by this paper
• Preparation of protein conjugates via intermolecular hydrazone linkage.

  1986cited by this paper
• [Immunodetermination of peptide factors. I. Synthesis of N-alpha-maleoyl-peptide derivatives].

  1985cited by this paper
• [Immunodetermination of peptide factors. I. Synthesis of N-alpha-maleoyl-peptide derivatives].

  1985cited by this paper
• Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level.

  1985cited by this paper
• Conjugation of glucose oxidase from Aspergillus niger and rabbit antibodies using N-hydroxysuccinimide ester of N-(4-carboxycyclohexylmethyl)-maleimide.

  1979cited by this paper
• Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent.

  1978cited by this paper
• Preparation and some properties of maleimido acids and maleoyl derivatives of peptides.

  1975cited by this paper

• Breaking Barriers in CRC Immunotherapy: Cutting-Edge Advances in Personalized Peptide Vaccine Development.

  2025cites this paper
• Evaluation of the immunoprotective power of a multiple antigenic peptide against Aah II toxin of Androctonus australis hector scorpion

  2024cites this paper
• Advancing Tumor Vaccines: Overcoming TME Challenges, Delivery Strategies, and Biomaterial-based Vaccine for Enhanced Immunotherapy.

  2024cites this paper
• Design of Potent and Salt-Insensitive Antimicrobial Branched Peptides

  2023cites this paper
• An Overview of Dendrimers as Novel Carriers in Drug Delivery

  2023cites this paper
• A review of treating viral outbreaks with self-assembled nanomaterial-like peptides: From Ebola to the Marburg virus

  2022cites this paper
• Protective immune potential of multiple antigenic peptide (MAP) constructs comprising peptides that are shared by several cysteine peptidases against Schistosoma mansoni infection in mice.

  2022cites this paper
• Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines

  2021cites this paper
• A novel polypeptide vaccine and Adjuvant Formulation of EV71.

  2021cites this paper
• Peptide Multimerization as Leads for Therapeutic Development

  2021cites this paper
• Recent progress on MHC-I epitope prediction in tumor immunotherapy.

  2021influential citation
• A REVIEW ON CHEMISTRY OF PEPTIDES

  2021cites this paper
• A bio-safe multiple antigenic peptide (MAP) enzyme-linked immunoassay for the detection of antibodies to infectious bronchitis virus in chickens

  2020cites this paper
• Designing Functionally Versatile, Highly Immunogenic Peptide-Based Multiepitopic Vaccines against Foot-and-Mouth Disease Virus

  2020cites this paper
• Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity.

  2020cites this paper
• Development of tumour peptide vaccines: From universalization to personalization

  2020cites this paper
• Dendrimers for pharmaceutical applications—potential and challenges

  2020cites this paper
• Development of a Bioconjugate Platform for Modifying the Immune Response of Autoreactive Cytotoxic T Lymphocytes Involved in Type 1 Diabetes.

  2019cites this paper
• Cytotoxicity of Dendrimers

  2019cites this paper
• Materials for Immunotherapy

  2019cites this paper
• Hapten synthesis and production of specific antibody against 3-amino-5-morpholinomethyl-2-oxazolidone for immunoassay without derivatisation

  2018influential citation
• Dendrimers-Based Nanoparticles for Cancer Therapy and Bioimaging

  2018cites this paper
• Chapter 5 References

  2017cites this paper
• Dendrimer-based nanocarriers: a versatile platform for drug delivery.

  2017cites this paper
• Medicinal Applications of Dendrimers

  2017cites this paper
• Conserved stem fragment from H3 influenza hemagglutinin elicits cross-clade neutralizing antibodies through stalk-targeted blocking of conformational change during membrane fusion.

  2016cites this paper
• Novel naproxen-peptide-conjugated amphiphilic dendrimer self-assembly micelles for targeting drug delivery to osteosarcoma cells

  2016cites this paper
• Nanoparticle-Based Peptide Vaccines

  2016cites this paper
• A Peptide Mimetic of 5-Acetylneuraminic Acid-Galactose Binds with High Avidity to Siglecs and NKG2D

  2015cites this paper
• A Targeted Multiple Antigenic Peptide Vaccine Augments the Immune Response to Self TGF-β1 and Suppresses Ongoing Hepatic Fibrosis

  2015cites this paper
• Polymeric Particulates for Subunit Vaccine Delivery

  2015cites this paper
• Immunogene synthetische oligopeptide

  2015cites this paper
• Synthetic peptides for the immunodiagnosis of hepatitis A virus infection.

  2015cites this paper
• Oligopeptides synthétiques immunogènes

  2015cites this paper
• Cell-surface glycan-lectin interactions for biomedical applications

  2015cites this paper
• Development of Peptidyl Lysine Dendrons: 1,3‐Dipolar Cycloaddition for Peptide Coupling and Antibody Recognition

  2015cites this paper
• Sequence-selective DNA recognition and enhanced cellular up-take by peptide-steroid conjugates.

  2015cites this paper
• Identification of human linear B-cell epitope sites on the envelope glycoproteins of Crimean-Congo haemorrhagic fever virus

  2014cites this paper
• Carbohydrate globules: molecular asterisk-cored dendrimers for carbohydrate presentation

  2014cites this paper
• Peptide scaffold conjugates as protein mimics for phosphate recognition

  2014cites this paper
• Immune responses to Crimean-Congo haemorrhagic fever virus and molecular characterization of viral isolates

  2014cites this paper
• Peptide-Based Polymer Therapeutics

  2014cites this paper
• Influence of conjugation chemistry and B epitope orientation on the immune response of branched peptide antigens.

  2013cites this paper
• Dendrimers in Biology and Nanomedicine

  2013cites this paper
• Site-directed in vitro mutagenesis of Enterovirus EV71: implications for the development of an attenuated EV71 vaccine

  2013cites this paper
• Production of polyclonal antibodies directed to recombinant methionyl bovine somatotropin.

  2013cites this paper
• Identification of coeliac disease triggering glutenin peptides and their measurement in foods

  2013cites this paper
• De novo DESIGN AND SYNTHESIS OF AN ICE-BINDING, DENDRIMERIC, POLYPEPTIDE BASED ON INSECT ANTIFREEZE PROTEINS

  2012influential citation
• Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells

  2012cites this paper
• A Bioorthogonal Chemoenzymatic Strategy for Defined Protein Dendrimer Assembly

  2012cites this paper
• Antitumor effect of new multiple antigen peptide based on HLA‐A0201‐restricted CTL epitopes of human telomerase reverse transcriptase (hTERT)

  2012cites this paper
• A novel dendrimeric peptide induces high level neutralizing antibodies against classical swine fever virus in rabbits.

  2012cites this paper
• SÍNTESE E DESENHO DE NOVO DE UM POLIPEPTÍDEOS DENDRÍMERO COM UNIÂO AO GELO BASEADO NAS PROTEÍNAS ANTICONGELANTES DE INSETOS

  2012influential citation
• Linear B-cell epitope mapping of neuraminidases of the 2009 A H1N1 viruses based on immunoinformatics.

  2011cites this paper
• Amino Acid‐Based Dendrimers

  2011cites this paper
• Strategy in Solid‐Phase Peptide Synthesis

  2011cites this paper
• Current strategies for subunit and genetic viral veterinary vaccine development.

  2011cites this paper
• Peptide vaccine candidates against classical swine fever virus: T cell and neutralizing antibody responses of dendrimers displaying E2 and NS2–3 epitopes

  2011cites this paper
• p185, an Immunodominant Epitope, Is an Autoantigen Mimotope*

  2011cites this paper
• Stabilized helical peptides: overview of the technologies and therapeutic promises

  2011cites this paper
• DNA Vaccination by Electrogene Transfer

  2011cites this paper
• peptide Mimetics of Terminal sugars of complex Glycans

  2010cites this paper
• High diagnostic efficiency of IgM-ELISA with the use of multiple antigen peptides (MAP1) from T. gondii ESA (SAG-1, GRA-1 and GRA-7), in acute toxoplasmosis.

  2010cites this paper
• Dendrimers for vaccine and immunostimulatory uses. A review.

  2010cites this paper
• Peptide Sugar Mimetics Prevent HIV Type 1 Replication in Peripheral Blood Mononuclear Cells in the Presence of HIV-Positive Antiserum

  2010cites this paper
• Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection.

  2010cites this paper
• Targeting human synovium using homing peptides identified by in vivo phage display

  2009cites this paper
• Dendritic Compounds as Immune Response Modulators. New Approaches for Vaccine Development

  2009cites this paper
• Multi-Tier Dendrimers with an Aromatic Core†

  2009cites this paper
• MAP dendrimer elicits antibodies for detecting rat and mouse GH‐binding proteins

  2009cites this paper
• Stabilising peptides of a sequential epitope of the Measles Virus Haemagglutinin protein and the implications for antigenicity and immunogenicity

  2009cites this paper
• Direct synthesis and characterisation of multi-dendritic peptides for use as immunogens.

  2009cites this paper
• Synthesis and characterization of a high-affinity αvβ6-specific ligand for in vitro and in vivo applications

  2009cites this paper
• Allergic Encephalomyelitis Experimental Development and Expression of Synthetic Peptide Dendrimers Block the

  2008cites this paper
• Enhanced Mucosal Immunoglobulin A Response and Solid Protection against Foot-and-Mouth Disease Virus Challenge Induced by a Novel Dendrimeric Peptide

  2008cites this paper
• Synthetic Peptide Dendrimers Block the Development and Expression of Experimental Allergic Encephalomyelitis1

  2008cites this paper
• Amphiphilic Dendrimeric Peptides as Model Non-Sequential Pharmacophores with Antimicrobial Properties

  2007influential citation
• The advance of dendrimers--a versatile targeting platform for gene/drug delivery.

  2007cites this paper
• Diffusion and conformation of peptide-functionalized polyphenylene dendrimers studied by fluorescence correlation and 13C NMR spectroscopy.

  2007cites this paper
• Detection of mutations in the 7A allele of wheat (Triticum aestivum) granule-bound starch synthase (Wx-7A) with a monoclonal antibody produced by targeted peptide immunisation

  2007cites this paper
• Reusable immunomagnetic beads in an enzyme immunoassay

  2007cites this paper
• Selection and syntheses of tentacle type peptides as 'artificial' lectins against various cell-surface carbohydrates.

  2007cites this paper
• Recent Advances in the Synthesis of Artificial Antigen and Its Application in the Detection of Pesticide Residue

  2007cites this paper
• Synthetic peptides for the immunodiagnosis of human diseases.

  2007cites this paper
• Doxorubicin-CdS nanoparticles: a potential anticancer agent for enhancing the drug uptake of cancer cells.

  2007cites this paper
• Towards the development of a broadly protective group a streptococcal vaccine based on the Lipid-Core Peptide system.

  2007cites this paper
• Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides.

  2007cites this paper
• Novel ligands for cancer diagnosis: selection of peptide ligands for identification and isolation of B-cell lymphomas.

  2006cites this paper
• Peptide Dendrimers as Immunogens

  2006cites this paper
• Preparation and properties of bio-compatible magnetic Fe3O4 nanoparticles

  2006cites this paper
• Oxidative amide synthesis and N-terminal alpha-amino group ligation of peptides in aqueous medium.

  2006cites this paper
• Polyphenylene dendrimers as scaffolds for shape-persistent multiple peptide conjugates.

  2005cites this paper
• Efficient synthesis of multifunctional furanoid C-glycoamino acid precursors

  2005cites this paper
• Isolation of a mycoplasma-specific binding peptide from an unbiased phage-displayed peptide library.

  2005cites this paper
• The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells.

  2005cites this paper
• Immune peptide enhancement of peptide based vaccines.

  2005cites this paper
• Synthetic carriers: sequential oligopeptide carriers SOCn-I and SOCn-II as an innovative and multifunctional approach.

  2005cites this paper
• Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes.

  2004cites this paper
• A Library-Selected, Langerhans Cell-Targeting Peptide Enhances an Immune Response

  2004influential citation
• Cell-specific delivery of a chemotherapeutic to lung cancer cells.

  2004cites this paper